Yousif Ahmad, MD
Cardiovascular Disease (Cardiology) · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Offices
- 5
- Since medical school
- 17 years
- Graduated 2009
Offices
5 locations · UCSF Medical Group Business Services · Regents of the University of California · University of California San Francisco
Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ahmad’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$92,964
Medicare paid this office $92,964 for 187 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 30 | $16,373 | $431 |
| Replacement of aortic valve through the skin and femoral artery | 18 | $11,108 | $617 |
| Long return visit (40+ min) | 57 | $7,293 | $114 |
| Removal of plaque, insertion of stent and balloon dilation of single coronary artery or branch | 11 | $6,953 | $497 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $6,203 | $102 |
See all 15 services
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 30 | $16,373 | $431 |
| Replacement of aortic valve through the skin and femoral artery | 18 | $11,108 | $617 |
| Long return visit (40+ min) | 57 | $7,293 | $114 |
| Removal of plaque, insertion of stent and balloon dilation of single coronary artery or branch | 11 | $6,953 | $497 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $6,203 | $102 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $6,191 | $144 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 32 | $5,424 | $170 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 48 | $4,013 | $77 |
| New patient visit (60+ min) | 19 | $2,928 | $154 |
| Shockwave destruction of calcified plaque in coronary artery accessed through skin using catheter | 22 | $2,811 | $122 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 21 | $1,240 | $59 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | 15 | $1,042 | $61 |
| Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | 11 | $651 | $27 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 21 | $386 | $15 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 32 | $336 | $10 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 158 | More than 98% of doctors who do this |
Procedures year by year
| Procedure | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Replacement of aortic valve through the skin and femoral artery | – | 23 | 14 | 18 |
| Placement and subsequent removal of device to protect brain from embolism through catheter using imaging guidance | – | 11 | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
187 Original Medicare patients in 2024. Average age 77 · Under 65 7% · 85 and older 25% · Women 32% · Also on Medicaid 26% · Health risk score 2.34. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 75% · Heart failure 75% · Diabetes 52% · Chronic kidney disease 51% · Atrial fibrillation 47% · Depression 29% · Cancer 26% · COPD 25% · Stroke 17% · Dementia 12%.
The office billed $750,015, Medicare allowed $117,817 and paid $92,964; for 615 services of 42 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 187 | 615 | 77 | 2.34 | $750,015 | $92,964 |
| 2023 | 248 | 917 | 77 | 1.93 | $1,026,826 | $138,677 |
| 2022 | 292 | 894 | 78 | 2.22 | $958,726 | $136,967 |
| 2021 | 54 | 179 | 76 | 2.22 | $166,894 | $26,802 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 44 | $25,652 | $435 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $11,178 | $147 |
| Long return visit (40+ min) | 79 | $11,150 | $117 |
| Removal of plaque, insertion of stent and balloon dilation of single coronary artery or branch | 16 | $9,866 | $519 |
| Replacement of aortic valve through the skin and femoral artery | 14 | $8,832 | $631 |
| Removal of plaque, insertion of stent and/or balloon dilation of single coronary artery, branch or bypass graft | 11 | $6,802 | $523 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 69 | $6,545 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $6,489 | $101 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 35 | $6,474 | $170 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 36 | $5,346 | $134 |
| Balloon dilation of single coronary artery or branch | 15 | $4,619 | $257 |
| Hospital discharge day management, more than 30 minutes | 33 | $3,305 | $97 |
| Return visit (30+ min) | 35 | $2,884 | $82 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 27 | $1,749 | $60 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | 20 | $1,446 | $63 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $1,309 | $82 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 101 | $1,287 | $11 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, each additional vessel | 11 | $481 | $44 |
| Ultrasonic guidance for blood vessel access | 24 | $287 | $12 |
2022: 19 services
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 35 | $16,740 | $408 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 85 | $15,851 | $167 |
| Replacement of aortic valve through the skin and femoral artery | 23 | $14,452 | $628 |
| Critical care, first 30-74 minutes | 21 | $10,441 | $183 |
| Long return visit (40+ min) | 59 | $9,509 | $122 |
| Removal of plaque, insertion of stent and balloon dilation of single coronary artery or branch | 13 | $7,567 | $504 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $6,591 | $86 |
| Hospital discharge day management, more than 30 minutes | 54 | $4,925 | $88 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 54 | $4,567 | $79 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 28 | $4,011 | $138 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 24 | $3,921 | $163 |
| Return visit (30+ min) | 18 | $1,497 | $83 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | 17 | $1,260 | $63 |
| Placement and subsequent removal of device to protect brain from embolism through catheter using imaging guidance | 11 | $1,218 | $111 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 18 | $1,081 | $60 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 84 | $990 | $11 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $947 | $59 |
| Hospital discharge day management, 30 minutes or less | 15 | $901 | $60 |
| Ultrasonic guidance for blood vessel access | 23 | $286 | $11 |
2021: 4 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,080 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,699 | $90 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 11 | $886 | $81 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 28 | $306 | $11 |
Medicaid work
$605 in 2023
Medicaid paid $605 for 13 billed services this clinician did in 2023, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 13 | $605 |
| 2023 | 13 | 1 | 13 | $605 |
| 2022 | 13 | 1 | 12 | $76 |
See the largest Medicaid services in earlier years
2022
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 13 | $76 |
Drugs they prescribed that Part D paid
$9,368
Pharmacies billed $9,368 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 97) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
86 generic and 11 brand-name prescriptions · $9,368 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Clopidogrel | 13 | $165 | $5 |
Year by year
| 2024 | 97 | 32 | 0% (0) | 11% | $9,368 |
| 2023 | 66 | 26 | 0% (0) | None | $6,495 |
| 2021 | 36 | 18 | 0% (0) | 61% | $16,665 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Clopidogrel | 12 | $126 | $10 |
2021: 2 drugs
| Brilinta | 20 | $15,236 | $762 |
| Clopidogrel | 13 | $121 | $9 |
Money from drug and device companies
$120,865 in 2025
| 2025 | 8 | 147 | $88,188 | $120,865 |
| 2024 | 6 | 46 | $18,375 | $22,833 |
| 2023 | 7 | 84 | $44,550 | $55,548 |
| 2022 | 7 | 16 | None | $1,372 |
| 2021 | 7 | 91 | None | $3,303 |
| 2020 | 1 | 53 | None | $1,124 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $74,016 | 24 payments
|
| Boston Scientific | General - Vascular Access | $34,323 | 56 payments
|
| Abiomed | None | $7,600 | 15 payments
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $4,091 | 40 payments
|
| Ancora Heart | Accucinch | $379 | 2 payments
|
| Abbott Laboratories | Triclip | $223 | 3 payments
|
See all 147 published payments
| Abiomed | Meals · 2025-12-31 | None | $55 |
| Boston Scientific | Paid to speak or teach · 2025-12-24 | General - Vascular Access | $3,750 |
| Edwards Lifesciences | Meals · 2025-12-23 | None | $17 |
| Boston Scientific | Consulting · 2025-12-18 | General - Ct Ic | $625 |
| Abbott Laboratories | Meals · 2025-12-16 | Optis | $19 |
| Edwards Lifesciences | Travel · 2025-12-12 | Sapien 3 Ultra Resilia | $100 |
| Edwards Lifesciences | Travel · 2025-12-12 | Sapien 3 Ultra Resilia | $114 |
| Shockwave Medical | Consulting · 2025-12-11 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $3,000 |
| Boston Scientific | Consulting · 2025-12-11 | General - Ct Ic | $3,125 |
| Edwards Lifesciences | Meals · 2025-12-09 | None | $62 |
| Edwards Lifesciences | Meals · 2025-12-01 | None | $8 |
| Abbott Laboratories | Meals · 2025-11-26 | Portico | $25 |
| Shockwave Medical | Meals · 2025-11-25 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $67 |
| Boston Scientific | Consulting · 2025-11-20 | General - Therapies | $938 |
| Edwards Lifesciences | Meals · 2025-11-20 | None | $39 |
| Boston Scientific | Meals · 2025-11-18 | Stingray | $170 |
| Edwards Lifesciences | Meals · 2025-11-15 | None | $58 |
| Edwards Lifesciences | Meals · 2025-11-14 | Sapien 3 Ultra Resilia | $63 |
| Edwards Lifesciences | Travel · 2025-11-14 | Sapien 3 Ultra Resilia | $460 |
| Edwards Lifesciences | Travel · 2025-11-14 | Sapien 3 Ultra Resilia | $82 |
| Edwards Lifesciences | Travel · 2025-11-14 | Sapien 3 Ultra Resilia | $101 |
| Edwards Lifesciences | Meals · 2025-11-14 | Sapien 3 Ultra Resilia | $17 |
| Edwards Lifesciences | Meals · 2025-11-14 | Sapien 3 Ultra Resilia | $16 |
| Edwards Lifesciences | Meals · 2025-11-14 | Sapien 3 Ultra Resilia | $53 |
| Edwards Lifesciences | Meals · 2025-11-14 | Sapien 3 Ultra Resilia | $13 |
| Shockwave Medical | Consulting · 2025-11-13 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $3,000 |
| Edwards Lifesciences | Travel · 2025-11-13 | Sapien 3 Ultra Resilia | $167 |
| Edwards Lifesciences | Travel · 2025-11-13 | Sapien 3 Ultra Resilia | $130 |
| Edwards Lifesciences | Meals · 2025-11-13 | Sapien 3 Ultra Resilia | $103 |
| Shockwave Medical | Consulting · 2025-11-12 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $3,000 |
| Boston Scientific | Meals · 2025-11-08 | General - Therapies | $170 |
| Boston Scientific | Travel · 2025-11-08 | General - Therapies | $303 |
| Boston Scientific | Meals · 2025-11-07 | General - Therapies | $118 |
| Boston Scientific | Travel · 2025-11-07 | General - Therapies | $300 |
| Edwards Lifesciences | Meals · 2025-11-03 | Sapien 3 Ultra Resilia | $6 |
| Edwards Lifesciences | Meals · 2025-11-03 | Sapien 3 Ultra Resilia | $15 |
| Shockwave Medical | Consulting · 2025-10-31 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $7,500 |
| Shockwave Medical | Consulting · 2025-10-31 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $1,500 |
| Edwards Lifesciences | Meals · 2025-10-30 | None | $9 |
| Abiomed | Meals · 2025-10-28 | None | $62 |
| Edwards Lifesciences | Meals · 2025-10-27 | None | $50 |
| Ancora Heart | Meals · 2025-10-26 | Accucinch | $316 |
| Teleflex | Meals · 2025-10-26 | Turnpike | $16 |
| Shockwave Medical | Travel · 2025-10-25 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $16 |
| Boston Scientific | Meals · 2025-10-25 | General - Therapies | $222 |
| Edwards Lifesciences | Meals · 2025-10-25 | Sapien 3 Ultra Resilia | $244 |
| Edwards Lifesciences | Consulting · 2025-10-23 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $625 |
| Edwards Lifesciences | Meals · 2025-10-22 | Sapien 3 Ultra Resilia | $6 |
| Abbott Laboratories | Meals · 2025-10-17 | Triclip | $179 |
| Boston Scientific | Meals · 2025-10-15 | Synergy | $5 |
| Boston Scientific | Paid to speak or teach · 2025-10-09 | General - Vascular Access | $5,000 |
| Boston Scientific | Paid to speak or teach · 2025-10-09 | General - Vascular Access | $625 |
| Boston Scientific | Travel · 2025-10-09 | General - Vascular Access | $357 |
| Boston Scientific | Travel · 2025-10-09 | General - Vascular Access | $222 |
| Abiomed | Meals · 2025-10-03 | None | $15 |
| Boston Scientific | Meals · 2025-10-03 | Avvigo Guidance System | $13 |
| Teleflex | Meals · 2025-10-03 | Vsi | $27 |
| Shockwave Medical | Consulting · 2025-10-02 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $3,000 |
| Shockwave Medical | Consulting · 2025-10-02 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $550 |
| Abiomed | Travel · 2025-10-02 | None | $293 |
| Abiomed | Travel · 2025-10-02 | None | $253 |
| Abiomed | Meals · 2025-10-02 | None | $131 |
| Abiomed | Meals · 2025-10-02 | None | $54 |
| Abiomed | Paid to speak or teach · 2025-10-02 | None | $5,100 |
| Abiomed | Travel · 2025-10-02 | None | $758 |
| Edwards Lifesciences | Travel · 2025-10-01 | None | $349 |
| Boston Scientific | Meals · 2025-09-29 | Opticross | $17 |
| Boston Scientific | Meals · 2025-09-23 | General - Therapies | $5 |
| Abiomed | Meals · 2025-09-16 | None | $23 |
| Abiomed | Paid to speak or teach · 2025-09-15 | None | $600 |
| Boston Scientific | Paid to speak or teach · 2025-09-10 | General - Vascular Access | $5,000 |
| Shockwave Medical | Consulting · 2025-08-28 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $4,500 |
| Shockwave Medical | Consulting · 2025-08-28 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $3,000 |
| Edwards Lifesciences | Meals · 2025-08-28 | None | $55 |
| Edwards Lifesciences | Meals · 2025-08-27 | None | $5 |
| Boston Scientific | Meals · 2025-08-26 | Rotapro | $17 |
| Boston Scientific | Meals · 2025-08-23 | Opticross | $8 |
| Boston Scientific | Meals · 2025-08-23 | General - Vascular Access | $236 |
| Boston Scientific | Meals · 2025-08-20 | Stingray | $11 |
| Ancora Heart | Meals · 2025-08-20 | Accucinch | $63 |
| Boston Scientific | Meals · 2025-08-19 | Opticross | $22 |
| Boston Scientific | Meals · 2025-08-19 | General - Atherectomy | $4 |
| Edwards Lifesciences | Meals · 2025-08-08 | Sapien 3 Ultra Resilia | $47 |
| Shockwave Medical | Meals · 2025-08-07 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $142 |
| Shockwave Medical | Travel · 2025-08-06 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $899 |
| Shockwave Medical | Travel · 2025-08-06 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $50 |
| Shockwave Medical | Travel · 2025-08-06 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $233 |
| Shockwave Medical | Meals · 2025-08-06 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $4,558 |
| Boston Scientific | Meals · 2025-08-05 | Avvigo Guidance System | $5 |
| Shockwave Medical | Consulting · 2025-07-31 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $3,000 |
| Shockwave Medical | Consulting · 2025-07-31 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $1,500 |
| Edwards Lifesciences | Meals · 2025-07-23 | Sapien 3 Ultra Resilia | $29 |
| Boston Scientific | Meals · 2025-07-12 | General - Therapies | $45 |
| Boston Scientific | Meals · 2025-07-02 | General - Atherectomy | $81 |
| Boston Scientific | Meals · 2025-07-02 | Opticross | $10 |
| Boston Scientific | Meals · 2025-07-01 | Opticross | $4 |
| Boston Scientific | Meals · 2025-07-01 | Wolverine Coronary Cutting Balloon | $19 |
| Edwards Lifesciences | Meals · 2025-06-27 | Sapien 3 Ultra Resilia | $62 |
| Edwards Lifesciences | Meals · 2025-06-26 | Sapien 3 Ultra Resilia | $38 |
| Edwards Lifesciences | Meals · 2025-06-26 | Sapien 3 Ultra Resilia | $156 |
| Edwards Lifesciences | Meals · 2025-06-26 | None | $152 |
| Abiomed | Meals · 2025-06-19 | None | $41 |
| Boston Scientific | Meals · 2025-06-17 | General - Atherectomy | $13 |
| Edwards Lifesciences | Meals · 2025-06-15 | Sapien 3 Ultra Resilia | $148 |
| Shockwave Medical | Consulting · 2025-06-12 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $5,250 |
| Shockwave Medical | Travel · 2025-06-12 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $11,250 |
| Shockwave Medical | Consulting · 2025-06-12 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $11,250 |
| Shockwave Medical | Travel · 2025-06-12 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $5,250 |
| Boston Scientific | Meals · 2025-06-12 | Wolverine Coronary Cutting Balloon | $8 |
| Boston Scientific | Meals · 2025-06-11 | General - Atherectomy | $7 |
| Edwards Lifesciences | Meals · 2025-06-09 | None | $6 |
| Edwards Lifesciences | Meals · 2025-05-30 | None | $77 |
| Medtronic | Meals · 2025-05-28 | Corevalve Evolut R | $153 |
| Teleflex | Meals · 2025-05-14 | Trapliner | $24 |
| Boston Scientific | Meals · 2025-05-09 | Opticross | $11 |
| Boston Scientific | Paid to speak or teach · 2025-05-01 | General - Vascular Access | $3,750 |
| Boston Scientific | Meals · 2025-04-29 | General - Atherectomy | $15 |
| Medtronic | Meals · 2025-04-25 | Corevalve Evolut R | $4 |
| Medtronic | Meals · 2025-04-25 | Corevalve Evolut R | $3 |
| Boston Scientific | Meals · 2025-04-22 | Synergy | $7 |
| Boston Scientific | Meals · 2025-04-22 | Expo | $10 |
| Boston Scientific | Consulting · 2025-04-17 | General - Balloons | $625 |
| Boston Scientific | Consulting · 2025-04-17 | General - Balloons | $6,875 |
| Boston Scientific | Travel · 2025-04-17 | General - Balloons | $178 |
| Boston Scientific | Meals · 2025-04-15 | Avvigo Guidance System | $7 |
| Boston Scientific | Meals · 2025-04-11 | Nc Emerge | $6 |
| Shockwave Medical | Consulting · 2025-04-10 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $750 |
| Boston Scientific | Meals · 2025-04-05 | Avvigo Guidance System | $219 |
| Boston Scientific | Meals · 2025-04-04 | General - Therapies | $35 |
| Boston Scientific | Travel · 2025-04-04 | Avvigo Guidance System | $240 |
| Boston Scientific | Travel · 2025-04-04 | Avvigo Guidance System | $383 |
| Boston Scientific | Meals · 2025-04-04 | Avvigo Guidance System | $231 |
| Boston Scientific | Meals · 2025-04-03 | Avvigo Guidance System | $33 |
| Boston Scientific | Meals · 2025-04-02 | Opticross | $8 |
| Edwards Lifesciences | Meals · 2025-03-30 | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $268 |
| Boston Scientific | Meals · 2025-03-28 | Avvigo Guidance System | $11 |
| Edwards Lifesciences | Meals · 2025-03-21 | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $31 |
| Boston Scientific | Meals · 2025-03-18 | Rotapro | $16 |
| Abiomed | Meals · 2025-02-28 | None | $47 |
| Abiomed | Meals · 2025-02-28 | None | $149 |
| Boston Scientific | Meals · 2025-02-20 | Avvigo Guidance System | $13 |
| Medtronic | Meals · 2025-02-14 | Corevalve Evolut R | $6 |
| Abiomed | Meals · 2025-02-12 | None | $19 |
| Edwards Lifesciences | Meals · 2025-02-12 | None | $112 |
| Boston Scientific | Meals · 2025-02-04 | General - Therapies | $173 |
| Shockwave Medical | Consulting · 2025-01-16 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $750 |
| Boston Scientific | Meals · 2025-01-07 | Stingray | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $22,833
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $10,110 | 4 payments
|
| Boston Scientific | Opticross | $7,474 | 17 payments
|
| Penumbra | Indigo System | $4,220 | 8 payments
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $455 | 8 payments
|
| Medtronic | Symplicity G3 | $440 | 8 payments
|
| Abiomed | Impella | $134 | 1 payment
|
2023: $55,548
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $36,976 | 24 payments
|
| Boston Scientific | Avvigo Guidance System | $9,608 | 15 payments
|
| Cardiovascular Systems | Diamondback Coronary | $4,191 | 3 payments
|
| Medtronic | Resolute Onyx | $3,735 | 31 payments
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $817 | 9 payments
|
| Abbott Laboratories | Diamondback Coronary | $123 | 1 payment
|
| Teleflex | Guideliner | $98 | 1 payment
|
2022: $1,372
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $352 | 4 payments
|
| Medtronic | Corevalve Evolut R | $314 | 4 payments
|
| Opsens | Optowire | $196 | 1 payment
|
| Boston Scientific | Avvigo Guidance System | $173 | 2 payments
|
| Cardiovascular Systems | Diamondback Coronary | $167 | 2 payments
|
| Teleflex | Turnpike | $146 | 1 payment
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $25 | 2 payments
|
2021: $3,303
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $1,943 | 71 payments
|
| Boston Scientific | General Atherectomy | $567 | 9 payments
|
| Philips Electronics North America | (6342) Intrasight Integ | $325 | 5 payments
|
| Medtronic | Corevalve Evolut | $223 | 2 payments
|
| Amgen | Repatha | $124 | 1 payment
|
| Biotronik | Pulsar | $109 | 2 payments
|
| W. L. Gore & Associates | Gore Cardioform Septal Occluder | $12 | 1 payment
|
2020: $1,124
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $1,124 | 53 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Shockwave Medical, Inc · Empower Cad · 2024 | Their institution | $52,221 |
| Shockwave Medical, Inc · Cosira-II · 2024 | Their institution | $50,974 |
| ShockWave Medical, Inc · Empower Cad · 2023 | Their institution | $28,730 |
| ShockWave Medical, Inc · Cosira-II · 2023 | Their institution | $24,495 |
| Shockwave Medical, Inc · Prospective, Multicenter, Single-Arm, Investigational Device Exemption (Ide) Study of the Shockwave Intravascular Lithotripsy (Ivl) System With the Shockwave Javelin Coronary Ivl Catheter (Forward Cad Ide Study) · 2025 | Their institution | $17,024 |
| Shockwave Medical, Inc · Efficacy of the Coronary Sinus Reducer in Patients With Refractory Angina II · 2025 | Their institution | $1,910 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 73.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1447716725
- Licence
- CT 69229
- Group
- UCSF Medical Group Business Services · Regents of the University of California · University of California San Francisco
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X)
- Mailing address
- 505 Parnassus Ave, San Francisco, CA, 94143
- NPI first listed
- 2019-02-12
- NPI last updated
- 2025-12-04
- NPI record certified
- 2025-12-04
This is when the NPI record was last certified, not a medical board exam.